🚨 Alpha Signal: Hanwha Life Insurance Co., Ltd. (088350.KS) 📉 Price Drop 6.2%

        March 23, 2026

🚨 Alpha Signal: Hanwha Life Insurance Co., Ltd. (088350.KS) 📉 Price Drop 6.2%

        🚨 Alpha Bond Signal Alert
Bond Market Analysis
Hanwha Life Insurance Co., Ltd. (088350.KS) -6.2% at 2026-03-23 09:32 JST from 2026-03-23 09:05 JST

🕒 Time (Local)
🌐 English Summary
📰 Original Headline (linked)

2026-03-12 09:22 KST
Seoul Economic reports that global proxy advisor ISS has recommended voting **against** Hanwha Life’s proposal to extend outside director terms from 2 to 3 years at the Mar. 24 AGM, warning the change would reduce board accountability to shareholders and harm shareholder interests, heightening governance‑risk concerns.
[\[단독\] 사외이사 임기 3년으로 늘리는 한화생명…ISS “주주 이익 침해로 반대”](https://v.daum.net/v/FQYW7HKpS6)

2026-03-12 08:13 KST
Hans경제’s sector preview of insurance AGMs notes that Hanwha Life will **not pay a dividend** at the upcoming Mar. 24 shareholders’ meeting despite record earnings, because surrender value reserves have exceeded 5 trillion won and capital buffers are tight, underlining weak dividend capacity and a less favorable shareholder‑return profile versus peers.
개정 상법 앞둔 보험사 주총…'지배구조 개편 분수령'

2026-02-23 18:04 KST
TopDaily details a “dividend resumption dilemma” at Hanwha Life: cash dividends have been suspended for 2024–2025, the K‑ICS solvency ratio has slipped to about 157% with limited Tier‑1 capital, and surrender value reserves are projected to exceed retained earnings by over 3 trillion won annually, implying **negative or minimal distributable profit** and a prolonged constraint on shareholder payouts.
한화생명, 이익보다 큰 해약환급금준비금에 배당 재개 '딜레마'

2026-02-23 15:42 KST
Yonhap reports that Hanwha Life’s Q4 2025 net income **fell 51.5% year‑on‑year** to 67.4 billion won, with operating income also down and only marginal sales growth, pointing to a sharp earnings deterioration into year‑end that can weigh on valuation after the stock’s strong prior rally.
Hanwha Life Insurance Q4 net income down 51.5 pct to 67.4 bln won

                                Don't miss what's next. Subscribe to Morning Espresso:

            Email address (required)

🕒 Time (Local)	🌐 English Summary	📰 Original Headline (linked)
2026-03-12 09:22 KST	Seoul Economic reports that global proxy advisor ISS has recommended voting against Hanwha Life’s proposal to extend outside director terms from 2 to 3 years at the Mar. 24 AGM, warning the change would reduce board accountability to shareholders and harm shareholder interests, heightening governance‑risk concerns.	[\[단독\] 사외이사 임기 3년으로 늘리는 한화생명…ISS “주주 이익 침해로 반대”](https://v.daum.net/v/FQYW7HKpS6)
2026-03-12 08:13 KST	Hans경제’s sector preview of insurance AGMs notes that Hanwha Life will not pay a dividend at the upcoming Mar. 24 shareholders’ meeting despite record earnings, because surrender value reserves have exceeded 5 trillion won and capital buffers are tight, underlining weak dividend capacity and a less favorable shareholder‑return profile versus peers.	개정 상법 앞둔 보험사 주총…'지배구조 개편 분수령'
2026-02-23 18:04 KST	TopDaily details a “dividend resumption dilemma” at Hanwha Life: cash dividends have been suspended for 2024–2025, the K‑ICS solvency ratio has slipped to about 157% with limited Tier‑1 capital, and surrender value reserves are projected to exceed retained earnings by over 3 trillion won annually, implying negative or minimal distributable profit and a prolonged constraint on shareholder payouts.	한화생명, 이익보다 큰 해약환급금준비금에 배당 재개 '딜레마'
2026-02-23 15:42 KST	Yonhap reports that Hanwha Life’s Q4 2025 net income fell 51.5% year‑on‑year to 67.4 billion won, with operating income also down and only marginal sales growth, pointing to a sharp earnings deterioration into year‑end that can weigh on valuation after the stock’s strong prior rally.	Hanwha Life Insurance Q4 net income down 51.5 pct to 67.4 bln won